Authors: Gehlert, DR Yang, PY George, C Wang, Y Schober, D Gackenheimer, S Johnson, D Beavers, LS Gadski, RA Baez, M

Citation: Dr. Gehlert et al., Cloning and characterization of rhesus monkey neuropeptide Y receptor subtypes, PEPTIDES, 22(3), 2001, pp. 343-350

Authors: Lin, HS Rampersaud, AA Richett, ME Harper, RW Beavers, LS McClure, DB Gardner, AJ Eacho, PI Foxworthy, PS Gadski, RA

Citation: Hs. Lin et al., Synthesis and in vitro biological activity of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha-ol: A 24,25-dehydro analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol, STEROIDS, 64(3), 1999, pp. 217-227

Authors: Lin, HS Rampersaud, AA Beavers, LS McClure, DB Gardner, AJ Eacho, PI Foxworthy, PS Gadski, RA

Citation: Hs. Lin et al., Synthesis and in vitro biological activity of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha,12 alpha-diol, a 12 alpha-hydroxyl analog of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha-ol: The latter is a potent activator of the low-density lipoprotein receptor promoter, STEROIDS, 64(10), 1999, pp. 735-741

Authors: Bensch, WR Gadski, RA Bean, JS Beavers, LS Schmidt, RJ Perry, DN Murphy, AT McClure, DB Eacho, PI Breau, AP Archer, RA Kauffman, RF

Citation: Wr. Bensch et al., Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters, J PHARM EXP, 289(1), 1999, pp. 85-92